Skip to content
PreclinicalResearch compoundLimited evidence

ISRIB

Experimental compound that blocks the cell stress response: improved memory in rodents, never studied in humans.

NootropicNeuroprotectiveMemoryNeuroprotectionnoo.affects.memorynoo.affects.focusnoo.affects.neuroprotection
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassMemory · Neuroprotection
Primary targeteIF2B activation – integrated stress response (ISR) inhibition
Targets3 receptor targets
Half-lifeNo human pharmacokinetic data
OnsetNo human data
EvidenceLimited evidence
Affected systemsnoo.affects.memorynoo.affects.focusnoo.affects.neuroprotection

Contents

DETAILED OVERVIEW

What is ISRIB?

ISRIB is an experimental compound developed to steer stressed cells back to normal protein production. It has not been approved as a medicine anywhere and was never cleared for human use; it exists as a research chemical, not intended for human consumption.

Under stress, cells slow down protein production, and ISRIB releases this brake, known as the integrated stress response. Because forming memories requires new proteins, researchers see this as the reason for the improvement. In rodents it improved learning and restored memory after head injury and in animal models of Alzheimer's disease, and in old mice it reversed age-related memory decline. It has not been studied in humans, so there is no data on its safety. The stress response also has a protective role, so the long-term consequences of blocking it for a long time are unknown, and in theory it could pose a risk in people with cancer. Safety in pregnancy and breastfeeding has not been established.

Mechanism

eIF2B activator / ISR inhibitor

Evidence

Preclinical only (no human data)

Legal status

Unapproved research chemical

Receptor profile

  • eIF2B (guanine-nucleotide exchange factor)Strong
  • eIF2-alpha phosphorylation block (ISR inhibition)Strong
  • Age-related memory declineModerate

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • No human safety data: only preclinical (rodent and cell) studies exist; the compound has never been tested in humans
  • The long-term consequences of sustained integrated stress response inhibition are unknown (the ISR serves an important protective and protein quality-control role)
  • Theoretical risk that switching off the ISR weakens cellular defenses against misfolded proteins or promotes aberrant survival
  • Poor water solubility, which historically complicated formulation and bioavailability
  • Unknown long-term safety and incomplete toxicity profile in humans

Contraindications · 3

  • Pregnancy and breastfeeding: safety not established, avoid
  • Cancer or elevated cancer risk: ISR inhibition may theoretically affect cell stress and survival pathways
  • Not an approved medicine; experimental research chemical, not recommended without clinical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

ISRIB is a research compound developed to dial down the cell's stress response, the goal being to get stressed cells back to making proteins normally. In animal studies it improved learning and memory, appeared to reverse age-related memory decline in older mice, and showed benefits in models of brain injury and Alzheimer's. Important caveat: all of this is animal-study evidence, there's no data yet on how it works in humans.

Telegram

Have a question about ISRIB?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC22H24Cl2N2O4
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.